Cholesterol and cost-effectiveness. Implications for practice, policy, and research.
McBride
P E
PE
Davis
J E
JE
D000924:Anticholesteremic Agents / Q000191:economics* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000191:economics* / Q000517:prevention & control; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care / Q000191:economics; D006801:Humans; D012106:Research
D000924:Anticholesteremic Agents